Workflow
23创01EB可交换公司债券
icon
Search documents
黑龙江珍宝岛药业股份有限公司关于控股股东 非公开发行可交换公司债券换股价格调整的提示性公告
登录新浪财经APP 搜索【信披】查看更多考评等级 2025年8月20日,创达集团针对本次换股价格向下修正事项召开债券持有人会议,审议通过《关于"23创 01EB"换股价格向下修正的议案》等议案,同意本次换股价格拟修正为12.35元/股。 根据上述决议,"23创01EB"的换股价格将从13.35元/股向下修正至12.35元/股,调整后的换股价格将于 2025年8月27日生效。本次换股价格下修后,创达集团本期可交债质押专户中预备用于交换的股票数量 仍满足第一期可交债全部换股所需的股票数量。 公司将密切关注本期可交债的进展情况,并根据有关规定履行持续信息披露义务,敬请广大投资者注意 投资风险。 特此公告。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 近日,黑龙江珍宝岛药业股份有限公司(以下简称"公司"或"珍宝岛")收到控股股东黑龙江创达集团有 限公司(以下简称"创达集团")的通知,创达集团2023年面向专业投资者非公开发行可交换公司债券 (第一期)(以下简称"第一期可交债")换股价格将进行调整,现将有关事项公告如下: 一、控股股 ...
黑龙江珍宝岛药业股份有限公司关于控股股东非公开发行可交换公司债券换股价格调整的提示性公告
Group 1 - The company announced a price adjustment for the exchangeable bonds issued by its controlling shareholder, Heilongjiang Chuangda Group Co., Ltd. [1][2] - The first phase of the exchangeable bonds, with a total issuance of 910 million yuan and a term of 3 years, was completed on April 11, 2023 [1] - The second phase of the exchangeable bonds, with a total issuance of 90 million yuan and a term of 3 years, was completed on June 28, 2023 [2] Group 2 - The company’s 2024 profit distribution plan includes a cash dividend of 1.50 yuan per 10 shares, totaling approximately 141.13 million yuan [3] - The adjusted cash dividend per share, after considering the total share capital dilution, will be 0.15 yuan per share [3] - The record date for the profit distribution is set for August 19, 2025, with the ex-dividend date and cash dividend payment date on August 20, 2025 [3] Group 3 - The adjustment of the exchange price for the bonds is based on the company's profit distribution and follows specific formulas outlined in the bond issuance prospectus [4][5] - The exchange price for the first phase bond will be adjusted from 13.50 yuan to 13.35 yuan per share, while the second phase bond will be adjusted from 10.69 yuan to 10.54 yuan per share [5] - The controlling shareholder has sufficient stock available for the exchange after the price adjustments [5]